|
|
Volumn 29, Issue 3, 2010, Pages 235-238
|
|
Editorial: The landmark approval of provenge®, what it means to immunology and "in this issue": The complex relation between vaccines and autoimmunity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
PROVENGE;
CANCER VACCINE;
SIPULEUCEL-T;
TISSUE EXTRACT;
AUTOIMMUNE DISEASE;
AUTOIMMUNITY;
CANCER GROWTH;
CANCER IMMUNIZATION;
CANCER SURVIVAL;
DRUG APPROVAL;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNE DEFICIENCY;
MOLECULAR MIMICRY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
PUBLICATION;
PUBLISHING;
SURVIVAL TIME;
IMMUNOLOGY;
MALE;
PROSTATE TUMOR;
RISK FACTOR;
AUTOIMMUNE DISEASES;
AUTOIMMUNITY;
CANCER VACCINES;
DRUG APPROVAL;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RISK FACTORS;
TISSUE EXTRACTS;
|
|
EID: 77953178485
PISSN: 08830185
EISSN: 15635244
Source Type: Journal
DOI: 10.3109/08830185.2010.490777 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|
